Using liver stiffness to predict varices in advanced liver cancer
Part of Cancer, Digestive system clinical trials.
This trial uses a simple ultrasound test (measuring liver and spleen stiffness) to predict if a patient with cirrhosis and advanced liver cancer has enlarged veins in the esophagus. The goal is to avoid unnecessary invasive procedures like endoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have cirrhosis (scarring of the liver) from any cause
- You have advanced liver cancer (HCC) and are about to start any type of systemic treatment (medication given through the bloodstream)
- You are willing and able to give written consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people over 18 who have advanced, long-term liver scarring. It uses specialized measurements of liver stiffness and pressure to confirm eligibility and may help doctors better understand this condition.
This trial tests if a special ultrasound technique combined with liver stiffness and platelet count can predict which patients with cirrhosis have high-risk varices in the esophagus or stomach, potentially reducing the need for repeated endoscopy.
This study uses a simple, non-invasive ultrasound test of your spleen and routine blood tests to see if your liver can start working better after treatment. It is for people whose cirrhosis has recently caused complications but who are now doing well on treatment.
This study tests whether ultrasound imaging can predict which patients with cirrhosis (scarring of the liver) are at higher risk of dangerous bleeding from enlarged veins in the esophagus. If successful, this could help doctors decide which patients need preventive treatment.
This trial is for people with liver cirrhosis who have high blood pressure in the vein that carries blood to the liver (portal hypertension). It uses a special ultrasound with contrast to learn more about the condition.
This trial uses a minimally invasive ultrasound technique to directly measure blood pressure in the liver's main vein. It may help doctors decide if patients with severe scarred livers need medication to prevent variceal bleeding.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.